Skip to content

Tucows TCX Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$96.7M+2.2%
Gross profit$24.1M+2.5%
Operating income-$4.3M-112%
Net income-$18.1M-19.7%

Balance sheet

See full
Cash & equivalents$44.3M+16.4%
Total debt$363.9M+12.5%
Total equity-$181.3M-67.5%
Total assets$729.2M-1.7%

Cash flow

See full
Operating cash flow$3.5M+131%
CapEx$5.5M+1.7%
Free cash flow-$2.0M+88.0%

Valuation

See full
Market cap$149.62M-30.4%
Enterprise value$469.18M-4.7%
P/S0.4×-0.2×

Profitability

See full
Gross margin30.8%
Operating margin10.4%
Net margin-20.1%-4.0pp
FCF margin-2.1%-1.0pp

Returns & leverage

See full
Return on equity-180.6%-217pp
Debt / equity25×+24.8×
Current ratio0.6×-0.4×